REFERENCE
GlaxoSmithKline.Important Prescribing Information. Company Communication: [3 pages], 4 Aug 2006. Available from: URL: http://www.fda.gov
Rights and permissions
About this article
Cite this article
New warnings added to Dexedrine labelling in the US. React. Wkly. 1116, 3 (2006). https://doi.org/10.2165/00128415-200611160-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200611160-00005